1. Home
  2. HYFM vs SNOA Comparison

HYFM vs SNOA Comparison

Compare HYFM & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

HOLD

Current Price

$0.81

Market Cap

4.0M

Sector

Industrials

ML Signal

HOLD

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

HOLD

Current Price

$1.24

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYFM
SNOA
Founded
1977
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.0M
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
HYFM
SNOA
Price
$0.81
$1.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.3K
87.9K
Earning Date
05-12-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.26
EPS
N/A
N/A
Revenue
$134,252,000.00
$19,529,000.00
Revenue This Year
$57.44
$23.00
Revenue Next Year
$5.71
$24.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.68
52 Week Low
$0.72
$0.85
52 Week High
$4.78
$6.92

Technical Indicators

Market Signals
Indicator
HYFM
SNOA
Relative Strength Index (RSI) 40.98 56.57
Support Level N/A $1.02
Resistance Level $1.07 $3.92
Average True Range (ATR) 0.08 0.06
MACD 0.00 0.02
Stochastic Oscillator 31.43 71.43

Price Performance

Historical Comparison
HYFM
SNOA

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: